Coagulation Profile Validity Period
In stable patients not on anticoagulants, coagulation profiles (PT/INR and aPTT) should be repeated if clinical decisions are needed beyond 24 hours from sample collection, with samples stored refrigerated; however, the clinical validity of these tests for predicting bleeding risk in non-anticoagulated patients is fundamentally questionable regardless of timing.
Storage Stability vs. Clinical Validity: Two Separate Issues
Laboratory Sample Stability
The research evidence provides clear guidance on how long plasma samples remain analytically stable:
Optimal Storage (Freezer):
- PT, INR, and aPTT remain stable for up to 36 hours when plasma is stored frozen, showing <10% change from baseline 1
Refrigerated Storage:
- PT and INR: stable for 24 hours (<10% change from baseline)
- aPTT: deteriorates at 12 hours (showing 12.1% change), making it unreliable beyond this timepoint 1
Room Temperature:
- All parameters (PT, INR, aPTT) deteriorate at 12 hours and should not be used 1
An earlier study found that plasma left on spun-down cells at room temperature could be used for add-on PT/APTT testing within 8 hours without clinically significant differences 2, though this is less conservative than the more recent data.
Critical Clinical Context
The more important issue is that PT/INR and aPTT have limited clinical validity outside their intended use. The PT/INR was specifically designed and validated only for monitoring vitamin K antagonist (VKA) therapy, not as a general screen for coagulopathy or bleeding risk 3. In patients not receiving VKA therapy, there is no high-quality evidence that INR values predict bleeding risk or that correcting mildly abnormal values provides clinical benefit 3.
Practical Algorithm for Clinical Use
For patients on warfarin/VKA therapy:
- Retest if clinical decision needed >24 hours after sample collection (refrigerated storage)
- Retest if >8-12 hours at room temperature
For stable patients NOT on anticoagulants:
- Question whether PT/INR testing is clinically indicated at all
- If truly needed for baseline assessment, samples refrigerated <24 hours are acceptable for PT/INR
- aPTT samples must be <12 hours old (refrigerated) or retested
For patients on heparin:
- aPTT monitoring samples should be <8 hours old for optimal reliability 2
Common Pitfalls
- Misusing INR in non-VKA patients: The INR lacks validity for predicting bleeding in liver disease, acute illness, or as a general coagulopathy screen 3
- Assuming all coagulation tests have equal stability: aPTT deteriorates faster than PT/INR in refrigerated storage 1
- Room temperature storage: Commonly done but significantly compromises test reliability after 8-12 hours 1, 2
- Lupus anticoagulant interference: Can falsely prolong PT/INR, particularly with recombinant thromboplastin reagents 4